about
RANTES/CCL5-induced pro-angiogenic effects depend on CCR1, CCR5 and glycosaminoglycansRANTES/CCL5 mediated-biological effects depend on the syndecan-4/PKCα signaling pathwayHeparanase and Syndecan-4 Are Involved in Low Molecular Weight Fucoidan-Induced Angiogenesis.Identification of a Pro-Angiogenic Potential and Cellular Uptake Mechanism of a LMW Highly Sulfated Fraction of Fucoidan from Ascophyllum nodosum.New prospects in the roles of the C-terminal domains of VEGF-A and their cooperation for ligand binding, cellular signaling and vessels formation.Abdominal aortic aneurysms targeted by functionalized polysaccharide microparticles: a new tool for SPECT imaging.Inhibition of VEGF expression in A431 and MDA-MB-231 tumour cells by cationic lipid-mediated siRNA delivery.Syndecan-1 and syndecan-4 are involved in RANTES/CCL5-induced migration and invasion of human hepatoma cells.Glycosaminoglycans and their synthetic mimetics inhibit RANTES-induced migration and invasion of human hepatoma cells.NADPH oxidase depletion in neutrophils from patients with cirrhosis and restoration via toll-like receptor 7/8 activation.miR-126 Is Involved in Vascular Remodeling under Laminar Shear Stress.Pro-angiogenic effect of RANTES-loaded polysaccharide-based microparticles for a mouse ischemia therapy.Glycosaminoglycan mimetics inhibit SDF-1/CXCL12-mediated migration and invasion of human hepatoma cells.Monocyte chemoattractant protein-1 (MCP-1)/CCL2 secreted by hepatic myofibroblasts promotes migration and invasion of human hepatoma cells.Low molecular weight fucoidan prevents intimal hyperplasia in rat injured thoracic aorta through the modulation of matrix metalloproteinase-2 expression.Fucoidan in a 3D scaffold interacts with vascular endothelial growth factor and promotes neovascularization in mice.Fucoidan/VEGF-based surface modification of decellularized pulmonary heart valve improves the antithrombotic and re-endothelialization potential of bioprostheses.Ultrasmall superparamagnetic iron oxide nanoparticles coated with fucoidan for molecular MRI of intraluminal thrombusOptimized multimodal nanoplatforms for targeting αvβ3 integrins
P50
Q28567974-346E6631-7A8E-444C-A400-4FAF420E23A6Q30592498-9114C7CD-04AA-4A0A-BE67-9FAA6BA97F14Q36329663-4F25EDB4-F1D5-4202-AA37-B828B1080C5FQ37370632-1839F180-3AAE-47C5-87F0-133D81C0D518Q38319139-D57516E7-628F-4E3D-9034-3F8F0DF33F1EQ38688674-7A5433CC-8E88-4029-B2C6-34CA0E92DA0EQ39369471-5BFB4D6F-6407-450F-B608-FD62ED93E8B2Q39820734-B7046D11-9054-4CFA-976E-CD780D301925Q40048147-266DC13E-A02F-48AB-B3C9-881CC6C046B6Q40177754-9BBD7860-DE8B-4BBB-A8AD-ADD3EA425243Q41421223-2458C4CC-4B72-41C0-B42D-72B459064BF6Q42378982-CD4EAA76-1B7C-4B4A-87D7-58005ECA179BQ43283594-29EB1C27-233B-4D5D-9D6D-66C6736CCF07Q44249273-121D25FF-DA6C-4007-93C7-072B6F4233A0Q47411438-008AC184-40D0-4088-BA15-FA3E5A4EE760Q53288329-19340598-7BA9-47FE-B646-F62BBEA688EBQ53689432-B23DC85B-F0F1-4147-8240-7AF6658E9DC2Q57183105-5ED30478-DECD-4ECB-AAB7-FE0094C34890Q63944635-8785B68B-6123-4E00-8A57-6CE8F74E3E3F
P50
description
hulumtues
@sq
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Oualid Haddad
@ast
Oualid Haddad
@en
Oualid Haddad
@es
Oualid Haddad
@nl
Oualid Haddad
@sl
type
label
Oualid Haddad
@ast
Oualid Haddad
@en
Oualid Haddad
@es
Oualid Haddad
@nl
Oualid Haddad
@sl
prefLabel
Oualid Haddad
@ast
Oualid Haddad
@en
Oualid Haddad
@es
Oualid Haddad
@nl
Oualid Haddad
@sl
P106
P21
P31
P496
0000-0002-3729-1038